This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aurigene Discovery Technologies Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Wohlfahrt Gerd: Innovator in PRMT5 Modulation
Introduction
Wohlfahrt Gerd is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Gerd holds a patent for "Imidazolidin-2-one compounds as PRMT5 modulators." This invention relates to derivatives of a compound of formula (I) and pharmaceutically acceptable salts thereof. The patent outlines methods for preparing these compounds and their use as PRMT5 inhibitors. These compounds are particularly useful as medicaments in treating conditions where PRMT5 inhibition is desired, such as cancer, metabolic disorders, inflammation, autoimmune diseases, and hemoglobinopathies.
Career Highlights
Wohlfahrt Gerd is associated with Aurigene Discovery Technologies Limited, where he applies his expertise in drug discovery and development. His work focuses on innovative approaches to combat various diseases through targeted therapies.
Collaborations
Gerd collaborates with talented professionals in his field, including Dinesh Chikkanna and Sunil Kumar Panigrahi. Their combined efforts contribute to advancing research and development in medicinal chemistry.
Conclusion
Wohlfahrt Gerd's contributions to the field of PRMT5 modulation highlight his innovative spirit and dedication to improving healthcare outcomes. His work continues to pave the way for new therapeutic options in the treatment of complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile